In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation
Cells · 2023
DOI: 10.3390/cells12060896 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Yavor K Bozhilov und 3 weiteren Autor:innen. Beteiligte Einrichtung: MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Megakaryocytes. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 356 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kay Kendall Leukaemia Fund, the National Institute of Health Research (NIHR) Oxford-Birmingham Blood and Transplant Research Unit in Advanced Cellular Therapies, the NIHR Oxford Biomedical Research Centre.
Abstract (Originalsprache)
The haematopoietic system plays an essential role in our health and survival. It is comprised of a range of mature blood and immune cell types, including oxygen-carrying erythrocytes, platelet-producing megakaryocytes and infection-fighting myeloid and lymphoid cells. Self-renewing multipotent haematopoietic stem cells (HSCs) and a range of intermediate haematopoietic progenitor cell types differentiate into these mature cell types to continuously support haematopoietic system homeostasis throughout life. This process of haematopoiesis is tightly regulated in vivo and primarily takes place in the bone marrow. Over the years, a range of in vitro culture systems have been developed, either to expand haematopoietic stem and progenitor cells or to differentiate them into the various haematopoietic lineages, based on the use of recombinant cytokines, co-culture systems and/or small molecules. These approaches provide important tractable models to study human haematopoiesis in vitro. Additionally, haematopoietic cell culture systems are being developed and clinical tested as a source of cell products for transplantation and transfusion medicine. This review discusses the in vitro culture protocols for human HSC expansion and differentiation, and summarises the key factors involved in these biological processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
ORCID-Profile: Yavor K Bozhilov, Ian Hsu, Elizabeth J Brown, Adam C Wilkinson
Förderung
- Kay Kendall Leukaemia Fund
- the National Institute of Health Research (NIHR) Oxford-Birmingham Blood and Transplant Research Unit in Advanced Cellular Therapies
- the NIHR Oxford Biomedical Research Centre
- the John Fell Fund
- the Christopher Welch Trust
Zitieren
APA
Bozhilov, Y. K., Hsu, I., Brown, E. J., & Wilkinson, A. C. (2023). In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation. Cells. https://doi.org/10.3390/cells12060896
Vancouver
Bozhilov YK, Hsu I, Brown EJ, Wilkinson AC. In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation. Cells. 2023. doi:10.3390/cells12060896
BibTeX
@article{Bozhilov2023,
author = {Bozhilov, Yavor K and Hsu, Ian and Brown, Elizabeth J and Wilkinson, Adam C},
title = {In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12060896}
}
EUVIMED